FDA Inspection 1160764 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on Nov 5, 2021 in Raleigh, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 5, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Raleigh, NC (United States)